A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Revenue | 10.0M | 10.0M | 12M | 14M | 9.3M | 6.9M |
| Net Income | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | $-4,885.69 | $-4,885.69 | $-4,527.59 | $-4,720.05 | $-4,708.33 | $-5,707.65 |
| Free Cash Flow | -4.9M | -4.9M | -5.5M | -5.7M | -7.9M | -8.6M |
| ROIC | 0.0% | - | -45.8% | -33.1% | -50.9% | - |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | - | - | 79.06 | 2.34 | 0.42 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -5.6M | -5.6M | -5.2M | -4.9M | -6.7M | -7.0M |
| Operating Margin | -55.9% | -55.9% | -43.6% | -35.6% | -71.6% | -101.1% |
| ROE | 0.0% | - | - | - | - | - |
| Shares Outstanding | 0M | 0M | 0M | 0M | 0M | 0M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 6.9M | 9.3M | 14M | 12M | 10.0M | 10.0M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -7.0M | -6.7M | -4.9M | -5.2M | -5.6M | -5.6M |
| Op. Margin | -101.1% | -71.6% | -35.6% | -43.6% | -55.9% | -55.9% |
| Net Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Margin | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | N/A | -50.9% | -33.1% | -45.8% | N/A | 0.0% |
| ROE | N/A | N/A | N/A | N/A | N/A | 0.0% |
| ROA | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Cash Flow | ||||||
| Op. Cash Flow | -8.6M | -7.9M | -5.7M | -5.5M | -4.9M | -4.9M |
| Free Cash Flow | -8.6M | -7.9M | -5.7M | -5.5M | -4.9M | -4.9M |
| Owner Earnings | -8.9M | -8.4M | -6.5M | -6.2M | -5.7M | -5.7M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 366K | 492K | 719K | 705K | 736K | 736K |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 366K | 492K | 719K | 705K | 736K | 736K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||
| Net Debt | -8.3M | 3.8M | 11M | 13M | 14M | -2.8M |
| Cash & Equiv. | 13M | 11M | 6.8M | 8.6M | 2.8M | 2.8M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.42 | 2.34 | 79.06 | N/A | N/A | 0.00 |
| Interest Coverage | -6.2 | -8.1 | -2.7 | -1.8 | -2.0 | -2.0 |
| Equity | 12M | 6.2M | 226K | -4.4M | -11M | -11M |
| Total Assets | 22M | 27M | 25M | 23M | 16M | 16M |
| Total Liabilities | 9.7M | 21M | 0 | 0 | 0 | 0 |
| Intangibles | 0 | 0 | 0 | 1.9M | 1.7M | 1.7M |
| Retained Earnings | -35M | -43M | -51M | -52M | -61M | -61M |
| Working Capital | 13M | 11M | 8.1M | 8.8M | -2.7M | -2.7M |
| Current Assets | 17M | 18M | 15M | 15M | 7.7M | 7.7M |
| Current Liabilities | 4.5M | 6.4M | 7.1M | 6.3M | 10M | 10M |
| Per Share Data | ||||||
| EPS | -5,707.65 | -4,708.33 | -4,720.05 | -4,527.59 | -4,885.69 | -4,885.69 |
| Owner EPS | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow/Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividends/Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Out. | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
| Valuation | ||||||
| P/E Ratio | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 0 | 0 | 0 | 0 | 0 | 0 |
| Avg. Price | 99.10 | 117.17 | 139.60 | 76.43 | 44.14 | 13.70 |
| Year-End Price | 115.38 | 146.37 | 100.34 | 60.72 | 32.28 | 13.70 |
Marinomed Biotech AG passes 0 of 9 quality checks, indicating weak fundamentals.
Marinomed Biotech AG (MARI-VI) has a 5-year average return on invested capital (ROIC) of -43.3%. This is below average and may indicate limited pricing power.
Marinomed Biotech AG (MARI-VI) does not currently pay a regular dividend.
Marinomed Biotech AG (MARI-VI) reported annual revenue of $10 million in its most recent fiscal year, based on SEC EDGAR filings.
Marinomed Biotech AG (MARI-VI) generated $-5 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Marinomed Biotech AG (MARI-VI) reported earnings per share (EPS) of $-4885.69 in its most recent fiscal year.
The Ledger Terminal provides 5 years of financial data for Marinomed Biotech AG (MARI-VI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.